T
Thirty Madison
Health Tech & Medtech · New York City, United States · Founded 2017
Thirty Madison is a family of specialized healthcare brands creating exceptional outcomes for all MoreLess
A virtual-first healthcare company that provides specialized care for people with chronic conditions. Thirty Madison has built a portfolio of brands, including Keeps for men's hair loss, Cove for migraine, Facet for skin conditions, and Nurx for women's health. The company's business model is centered on a direct-to-consumer approach, offering online consultations with healthcare providers, personalized treatment plans, and home delivery of medications and products. This model aims to improve access to care and make it more affordable and convenient for patients.
Thirty Madison generates revenue by selling its specialized healthcare services and products. Patients typically pay for consultations and subscribe to receive regular shipments of their prescribed treatments. The company has a significant user base, with over 750,000 active patients, and has established itself as a key player in the telehealth market. By focusing on specific chronic conditions, Thirty Madison is able to provide targeted and effective care, which has resonated with consumers looking for more specialized healthcare solutions.
Keywords: telehealth, direct-to-consumer healthcare, chronic conditions, specialized care, virtual healthcare, subscription healthcare, digital health, online pharmacy, women's health, men's health
Company overview
Thirty Madison company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2017
- Headquarters
- New York City, United States
- Employees
- 208
- Open positions
- 4
- Dealroom signal
- 62.0
- Investment activity
- 1 companies · latest Feb 2022
- Capital deployed
- —
- Preferred round
- MERGER
Valuation & funding
Thirty Madison funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2025 | $500M | $500M | Remedy Meds | ↗ |
| SECONDARYOther financing | Apr 2024 | $1.3M | — | Undisclosed | — |
| MERGEROther financing | Feb 2022 | $0 | — | NURX | ↗ |
| SERIES COther financing | Jun 2021 | $140M | $1B | Mousse Partners · HealthQuest Capital · Northzone · Greycroft Partners | ↗ |
| SERIES BOther financing | Aug 2020 | $47M | $188M | Northzone · Johnson & Johnson Innovation · Maveron · Polaris Partners | — |
| EARLY VCOther financing | Mar 2020 | Undisclosed | — | ||
| SERIES AOther financing | Oct 2018 | Greycroft Partners · Northzone · Maveron | — | ||
| SEEDOther financing | Nov 2017 | Greycroft Partners · First Round Capital · Maveron | — | ||
| SEEDOther financing | May 2017 | Undisclosed | — |
Growth signals
Thirty Madison website traffic
Latest recorded traffic for Thirty Madison is 6.1K monthly website visits, down 15.3% over the last three months. Thirty Madison's team declined 31.8% over the past year.
Hiring
Open positions at Thirty Madison
Current openings linked to this company in Dealroom.
Comparisons
Thirty Madison compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Thirty Madison investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
NURXSan Francisco, United StatesTelemedicine platform focused on birth control and HIV prevention
$268Mvaluation
CoveNew York City, United StatesPrescription Medication for Migraine Relief | Cove
→
KeepsNew York City, United StatesHealth-care company focused on male pattern baldness prevention and treatment
$61Mvaluation
Talent graph
Thirty Madison's talent
Source: Dealroom Talent Intelligence.
Investors
11 investors on Thirty Madison's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Thirty Madison has talent and traffic
team presence
In the news
Latest news about Thirty Madison
Recent press, funding announcements, and product moves mentioning Thirty Madison — open to read from the original sources.
Market sentiment
What the market is saying about Thirty Madison
An AI-synthesized read of the highest-engagement posts about Thirty Madison on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Thirty Madison’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.